5news.Australian news, all in one place

BREAKING

› Even if the glass cliff does exist, the cancellation cliff is more dangerous › Dragons ready to make play for Kangaroos debutant › Y2K makeup is making a comeback. Here’s how you can create a Zara Larsson inspired makeup look for under $25 › Not since 1974 has Sydney got behind a rugby league Test like this. One Kiwi cannot wait › Australia facing biggest jobless rate rise of developed world › Fresh concerns over 2027 Asian Cup in Saudi Arabia after missile strikes in Riyadh › Australian politics live: Climate protester restrained after interrupting NSW parliament; Liberal says PM should be ‘stoned in the square’ over ATO credit card ban › Outdoor recreation taken into the fold as the new koala park draws closer › Libs dump candidate over risk party affairs could be exposed in legal brawl › Labor says it can’t force coronial inquests in WA. The opposition wants to change that › Even if the glass cliff does exist, the cancellation cliff is more dangerous › Dragons ready to make play for Kangaroos debutant › Y2K makeup is making a comeback. Here’s how you can create a Zara Larsson inspired makeup look for under $25 › Not since 1974 has Sydney got behind a rugby league Test like this. One Kiwi cannot wait › Australia facing biggest jobless rate rise of developed world › Fresh concerns over 2027 Asian Cup in Saudi Arabia after missile strikes in Riyadh › Australian politics live: Climate protester restrained after interrupting NSW parliament; Liberal says PM should be ‘stoned in the square’ over ATO credit card ban › Outdoor recreation taken into the fold as the new koala park draws closer › Libs dump candidate over risk party affairs could be exposed in legal brawl › Labor says it can’t force coronial inquests in WA. The opposition wants to change that

Australian News

NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

Brisbane Times · 13 October 2026 at 2:58 pm

NeuroScientific Biopharmaceuticals clears key US Crohn’s trial hurdle

NeuroScientific Biopharmaceuticals has landed key US backing for its Phase 2 stem cell Crohn’s trial, green-lighting a planned year-end start subject to final preparations.

Read the full article on Brisbane Times ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.brisbanetimes.com.au — the content belongs to Brisbane Times.

More from Brisbane Times

Dragons ready to make play for Kangaroos debutant

Brisbane Times · 5 min ago

Not since 1974 has Sydney got behind a rugby league Test like this. One Kiwi cannot wait

Brisbane Times · 7 min ago

Australia facing biggest jobless rate rise of developed world

Brisbane Times · 9 min ago

Outdoor recreation taken into the fold as the new koala park draws closer

Brisbane Times · 12 min ago

More in Australian News

Dragons ready to make play for Kangaroos debutant

Brisbane Times · 5 min ago

Not since 1974 has Sydney got behind a rugby league Test like this. One Kiwi cannot wait

Brisbane Times · 7 min ago

Australia facing biggest jobless rate rise of developed world

Brisbane Times · 9 min ago

Outdoor recreation taken into the fold as the new koala park draws closer

Brisbane Times · 12 min ago

Libs dump candidate over risk party affairs could be exposed in legal brawl

Brisbane Times · 13 min ago

Labor says it can’t force coronial inquests in WA. The opposition wants to change that

Brisbane Times · 16 min ago